Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Markham

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Drugs|January 12, 2021
REGN-EB3: First ApprovalAnthony Markham
Drugs|October 19, 2020
Correction to: Oliceridine: First ApprovalAnthony Markham
Drugs|September 9, 2020
Correction to: Fostemsavir: First ApprovalAnthony Markham
Drugs|October 7, 2020
Oliceridine: First ApprovalAnthony Markham
Drugs|December 11, 2020
Correction to: Selpercatinib: First ApprovalAnthony Markham
Drugs|May 4, 2020
Tepotinib: First ApprovalAnthony Markham
Drugs|June 20, 2020
Selpercatinib: First ApprovalAnthony Markham
Drugs|May 8, 2019
Solriamfetol: First Global ApprovalAnthony Markham
Drugs|April 21, 2018
Ibalizumab: First Global ApprovalAnthony Markham
Drugs|May 31, 2018
Correction to: Ibalizumab: First Global ApprovalAnthony Markham
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Drugs|January 12, 2021
REGN-EB3: First ApprovalAnthony Markham
Drugs|October 19, 2020
Correction to: Oliceridine: First ApprovalAnthony Markham
Drugs|September 9, 2020
Correction to: Fostemsavir: First ApprovalAnthony Markham
Drugs|October 7, 2020
Oliceridine: First ApprovalAnthony Markham
Drugs|December 11, 2020
Correction to: Selpercatinib: First ApprovalAnthony Markham
Drugs|May 4, 2020
Tepotinib: First ApprovalAnthony Markham
Drugs|June 20, 2020
Selpercatinib: First ApprovalAnthony Markham
Drugs|May 8, 2019
Solriamfetol: First Global ApprovalAnthony Markham
Drugs|April 21, 2018
Ibalizumab: First Global ApprovalAnthony Markham
Drugs|May 31, 2018
Correction to: Ibalizumab: First Global ApprovalAnthony Markham
Pageof 9